Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics

Clinical trial NCT00421187 · TERMINATED

Trial details

NCT number: NCT00421187
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Febrile Neutropenia

Start date: 2007-03-01
Primary completion: 2008-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.